CJC-1295 / Ipamorelin Research Material
CJC-1295 / Ipamorelin is a combined peptide research material supplied in vial format for laboratory environments, commonly included in studies focused on peptide signalling and growth hormone-related pathways.
CJC-1295 is a synthetic peptide analogue studied for its role in growth hormone releasing pathways, while Ipamorelin is a selective agonist evaluated for its interaction with ghrelin receptors.
Together, this combination is examined in research exploring coordinated peptide activity and peptide signaling interactions.
What is CJC-1295 / Ipamorelin?
CJC-1295 / Ipamorelin is a combined research material commonly studied in laboratory settings focused on peptide interaction and signaling pathways.
This pairing is frequently examined due to its complementary roles in controlled research environments involving regulated hormone signaling.
Related Research Materials
Often grouped with NAD+ 500mg Research Material and Klow 80mg Research Material, this combination is commonly included in broader peptide-focused research models.
Physical & Handling Characteristics
- Lyophilised powder format
- Supplied in sealed vial
- Requires reconstitution prior to use
- Intended for controlled laboratory environments
- Stored under appropriate research conditions
Cjc/ Ipamorelin is available in a 10 mg format within our research materials range